Jazz Pharmaceuticals’ CBD drug shows promise beyond seizure reduction

Green Market Report
By Adam JacksonSep 5, 2024, 10:19 am167 ptsTop
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced plans to present eight abstracts at an upcoming major conference in Europe, showcasing new data on its cannabidiol (CBD) epilepsy treatment. The survey, which the company will present at the 15th European Epilepsy Congress in Rome next week, found that 87% of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Metrc debuts labeling feature to ease cannabis inventory challenges 69

Federal Appeals Court Hears Challenge To Gun Ban For Marijuana Consumers 69

Florida approves 22 applicants for medical marijuana dispensary licenses 69

Canopy Growth names Luc Mongeau as its next CEO 68

LeafLink buys online wholesale competitor Leaf Trade 63

Marijuana operator Gold Flora facing receivership amid financial challenges 62

Kentucky issues medical marijuana permits amid out-of-state controversy 62

Teens in Danger: How Marijuana Legalization is Fueling a Youth Addiction Crisis 61

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.